Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Does fortune foul fidelity?

Spillman MA, Sade R.

Am J Bioeth. 2011 Sep;11(9):14-5. doi: 10.1080/15265161.2011.593688. No abstract available.

PMID:
21877965
2.

Blind spots.

Trachtman H.

Am J Bioeth. 2011 Sep;11(9):16-8. doi: 10.1080/15265161.2011.596988. No abstract available.

PMID:
21877966
3.

Understanding corporate responsibility: culture and complicity.

Degeling C, Townley C, Rogers W.

Am J Bioeth. 2011 Sep;11(9):18-20. doi: 10.1080/15265161.2011.593690. No abstract available.

PMID:
21877967
4.

Foxes guarding the henhouse: systemic responsibility for corporate harms.

Hall A.

Am J Bioeth. 2011 Sep;11(9):10-1. doi: 10.1080/15265161.2011.593689. No abstract available.

PMID:
21877963
5.

Challenging the idea of corporate responsibility: physician's obligation to disclose information.

Chiapperino L, Oishi JO.

Am J Bioeth. 2011 Sep;11(9):20-1. doi: 10.1080/15265161.2011.593687. No abstract available.

PMID:
21877968
6.

Corporate moral culpability in health care: when the implications don't fit the crime.

Harter TD.

Am J Bioeth. 2011 Sep;11(9):12-3. doi: 10.1080/15265161.2011.593684. No abstract available.

PMID:
21877964
7.

Impairing loyalty: corporate responsibility for clinical misadventure.

Kipnis K.

Am J Bioeth. 2011 Sep;11(9):3-9. doi: 10.1080/15265161.2011.598382.

PMID:
21877962
8.

Lunch with Lilly: who pays?

Strong C.

Am J Bioeth. 2003 Summer;3(3):62-3. No abstract available.

PMID:
14594499
9.

The Corporate Practice of Medicine: An Old Conflict Continues in New Forms.

Johnson S.

Md Med. 2015;16(2):15-7. No abstract available.

PMID:
26470498
10.

The neglected repercussions of a physician advertising ban.

Zwier S.

J Med Ethics. 2014 Mar;40(3):198-201. doi: 10.1136/medethics-2012-101078.

PMID:
23557909
11.

The death of common sense.

Trachtman H.

Am J Bioeth. 2003 Summer;3(3):W31-W32. No abstract available.

PMID:
14594484
12.

The physician and the pharmaceutical industry: both must keep the patient's interests at heart.

Ravindran GD.

Issues Med Ethics. 1999 Jan-Mar;7(1):21-2. No abstract available.

PMID:
16320467
13.

Collaborations between surgeons and industry are productive and beneficial to patients.

Nakayama D.

J Am Coll Surg. 2010 Jul;211(1):146-7; author reply 147. doi: 10.1016/j.jamcollsurg.2010.04.009. No abstract available.

PMID:
20610270
14.

Commentary: Lack of scientific influences on epidemiology.

Phillips CV.

Int J Epidemiol. 2008 Feb;37(1):59-64; discussion 65-8. doi: 10.1093/ije/dym266. No abstract available.

PMID:
18245053
15.

[From service of charity to profit center? An ethical critique of commodification of medicine].

Maio G.

Med Klin (Munich). 2008 Jun 15;103(6):455-9. doi: 10.1007/s00063-008-1066-3. German.

PMID:
18548217
16.

Confidentiality.

Murrell KJ.

Linacre Q. 1993 Aug;60(3):75-80. No abstract available.

PMID:
11652905
17.

Industry-to-physician marketing and the cost of prescription drugs.

Chiong W.

Am J Bioeth. 2003 Summer;3(3):W28-W29. No abstract available.

PMID:
14594480
18.

Direct-to-consumer advertising of health-related goods and services.

Thompson D.

Am J Bioeth. 2014;14(3):53-4. doi: 10.1080/15265161.2013.879961. No abstract available.

PMID:
24592845
19.

Three reasons to ban advertising for health care services.

Delmas C.

Am J Bioeth. 2014;14(3):51-2. doi: 10.1080/15265161.2013.879958. No abstract available.

PMID:
24592844
20.

Capitalism works for health care too.

Zivotofsky AZ, Zivotofsky NT.

Am J Bioeth. 2014;14(3):56-8. doi: 10.1080/15265161.2013.879956. No abstract available.

PMID:
24592847

Supplemental Content

Support Center